Key result
Obstructive CAD on CCTA is linked to a ~5.7-fold higher event risk despite zero CAC.
Why the study?
Does the presence of obstructive CAD on CCTA predict adverse events in symptomatic patients with a CAC score of 0?
Cohort (n=10,037)
Does the presence of obstructive CAD on CCTA predict adverse events in symptomatic patients with a CAC score of 0?
Answers are grounded in this paper and cite their sources.
In symptomatic patients with a CAC score of 0, obstructive CAD is present in 3.5% of cases and is associated with a significantly increased risk of cardiovascular events, highlighting that a zero CAC score does not entirely rule out high-risk disease.
OBJECTIVES The purpose of this study was to describe the prevalence and severity of coronary artery disease (CAD) in relation to prognosis in symptomatic patients without coronary artery calcification (CAC) undergoing coronary computed tomography angiography (CCTA). BACKGROUND The frequency and clinical relevance of CAD in patients without CAC are unclear. METHODS We identified 10,037 symptomatic patients without CAD who underwent concomitant CCTA and CAC scoring. CAD was assessed as <50%, ≥50%, and ≥70% stenosis. All-cause mortality and the composite endpoint of mortality, myocardial infarction, or late coronary revascularization (≥90 days after CCTA) were assessed. RESULTS Mean age was 57 years, 56% were men, and 51% had a CAC score of 0. Among patients with a CAC score of 0, 84% had no CAD, 13% had nonobstructive stenosis, and 3.5% had ≥50% stenosis (1.4% had ≥70% stenosis) on CCTA. A CAC score >0 had a sensitivity, specificity, and negative and positive predictive values for stenosis ≥50% of 89%, 59%, 96%, and 29%, respectively. During a median of 2.1 years, there was no difference in mortality among patients with a CAC score of 0 irrespective of obstructive CAD. Among 8,907 patients with follow-up for the composite endpoint, 3.9% with a CAC score of 0 and ≥50% stenosis experienced an event (hazard ratio: 5.7; 95% confidence interval: 2.5 to 13.1; p < 0.001) compared with 0.8% of patients with a CAC score of 0 and no obstructive CAD. Receiver-operator characteristic curve analysis demonstrated that the CAC score did not add incremental prognostic information compared with CAD extent on CCTA for the composite endpoint (CCTA area under the curve = 0.825; CAC + CCTA area under the curve = 0.826; p = 0.84). CONCLUSIONS In symptomatic patients with a CAC score of 0, obstructive CAD is possible and is associated with increased cardiovascular events. CAC scoring did not add incremental prognostic information to CCTA.
No takes yet. Share an insight, caveat, or question.
Villines et al. (2011) conducted a cohort in Symptomatic patients undergoing CCTA (n=10,037). Obstructive CAD (≥50% stenosis) on CCTA vs. No obstructive CAD was evaluated on Composite of mortality, myocardial infarction, or late coronary revascularization (≥90 days after CCTA) (HR 5.7, 95% CI 2.5 to 13.1, p=< 0.001). In symptomatic patients with a CAC score of 0, obstructive CAD on CCTA increased the risk of mortality, MI, or late revascularization compared to no obstructive CAD (HR 5.7; 95% CI 2.5-13.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: